Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 192, 114743
Abstract
No abstract availableKeywords
Funding Information
- National Science and Technology Development Agency
- National Research Council of Thailand
- State Corporation Commission (2563NRCT321511)
- Faculty of Medicine, Prince of Songkla University
- Chiang Mai University
This publication has 61 references indexed in Scilit:
- Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin‐resistant ratsBritish Journal of Pharmacology, 2013
- Protective effect of melatonin against Adriamycin-induced cardiotoxicityExperimental and Therapeutic Medicine, 2013
- Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in MicePLOS ONE, 2012
- Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagyCell Death & Disease, 2012
- Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in RatsOxidative Medicine and Cellular Longevity, 2012
- Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin‐ and trastuzumab‐induced cardiotoxicityJournal of Pineal Research, 2010
- CardiotoxicityAnnals of Oncology, 2010
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998